News
BAYRY
13.09
-0.23%
-0.03
Weekly Report: what happened at BAYRY last week (0720-0724)?
Weekly Report · 1h ago
SA Asks: How will Trump's new tariffs impact the EU trade deal?
Seeking Alpha · 13h ago
Regeneron: I'm Not Concerned About The Declining ROIC And Operating Margins
Seeking Alpha · 2d ago
Bayer Refines Nurandociguat Tablet in New Phase 1 Study, Keeping CKD Pipeline on Track
TipRanks · 2d ago
J&J, Gilead among recipients of EU drug recommendations this week
Seeking Alpha · 2d ago
EMA'S CHMP: RECOMMENDS GRANTING MARKETING AUTHORISATION FOR RUXOLITINIB VIATRIS
Reuters · 3d ago
Bayer calls XS2630111982 notes for early redemption on Aug. 11, 2026
PUBT · 3d ago
New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters
Barchart · 3d ago
Kairos Pharma announces collaboration with Bayer to enhance XOFIGO
TipRanks · 4d ago
Kairos Pharma partners with Bayer to test ENV-105 with Xofigo in metastatic prostate cancer
PUBT · 4d ago
KAIROS PHARMA: TO EVALUATE CO'S LEAD ANTIBODY ENV-105 WITH BAYER'S XOFIGO IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Reuters · 4d ago
ValuEngine Weekly Market Summary And Commentary
Seeking Alpha · 5d ago
Amundi cuts Bayer voting rights stake to 2.96% from 3.09%
PUBT · 6d ago
Weekly Report: what happened at BAYRY last week (0713-0717)?
Weekly Report · 07/20 09:35
Northern Data appoints Chief Legal Officer Rudolf Haas to management board
PUBT · 07/18 06:00
Bayer, Henry Ford Health partner to expand access to clinical trials
TipRanks · 07/17 12:40
BRIEF-Bayer And Henry Ford Health Announce Strategic Research Partnership
Reuters · 07/17 12:36
J.P. Morgan Keeps Their Buy Rating on Bayer (0P6S)
TipRanks · 07/17 11:56
Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials
Barchart · 07/17 07:30
Sanofi sues Pfizer, Moderna over COVID shot technology
Reuters · 07/15 15:56
More
Webull provides a variety of real-time BAYRY stock news. You can receive the latest news about Bayer Aktien through multiple platforms. This information may help you make smarter investment decisions.
About BAYRY
Bayer AG is a German-based life science company. The Company's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.